{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T18:41:55Z","timestamp":1742928115635,"version":"3.40.3"},"publisher-location":"Cham","reference-count":113,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030620257"},{"type":"electronic","value":"9783030620264"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-62026-4_2","type":"book-chapter","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T10:15:11Z","timestamp":1628504111000},"page":"7-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors"],"prefix":"10.1007","author":[{"given":"Milica","family":"Vucetic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boutaina","family":"Daher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamir","family":"Cassim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Parks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Pouyssegur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"issue":"4","key":"2_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","volume":"53","author":"C Almoguera","year":"1988","unstructured":"Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53(4):549\u2013554. https:\/\/doi.org\/10.1016\/0092-8674(88)90571-5","journal-title":"Cell"},{"issue":"19","key":"2_CR2","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1073\/pnas.1814932116","volume":"116","author":"MD Arensman","year":"2019","unstructured":"Arensman MD, Yang XS, Leahy DM, Toral-Barza L, Mileski M, Rosfjord EC et al (2019) Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity. Proc Natl Acad Sci U S A 116(19):9533\u20139542. https:\/\/doi.org\/10.1073\/pnas.1814932116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6486","key":"2_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V et al (2020) Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science 368(6486):85\u201389. https:\/\/doi.org\/10.1126\/science.aaw9872","journal-title":"Science"},{"issue":"19","key":"2_CR4","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1158\/1078-0432.CCR-12-0214","volume":"18","author":"S Baek","year":"2012","unstructured":"Baek S, Choi CM, Ahn SH, Lee JW, Gong G, Ryu JS et al (2012) Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer. Clin Cancer Res 18(19):5427\u20135437. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0214","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2967\/jnumed.112.108704","volume":"54","author":"S Baek","year":"2013","unstructured":"Baek S, Mueller A, Lim YS, Lee HC, Lee YJ, Gong G et al (2013) (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies. J Nucl Med 54(1):117\u2013123. https:\/\/doi.org\/10.2967\/jnumed.112.108704","journal-title":"J Nucl Med"},{"issue":"5","key":"2_CR6","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","volume":"261","author":"S Bannai","year":"1986","unstructured":"Bannai S (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 261(5):2256\u20132263","journal-title":"J Biol Chem"},{"issue":"1","key":"2_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01870891","volume":"89","author":"S Bannai","year":"1986","unstructured":"Bannai S, Tateishi N (1986) Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol 89(1):1\u20138","journal-title":"J Membr Biol"},{"issue":"31","key":"2_CR8","doi-asserted-by":"publisher","first-page":"18480","DOI":"10.1016\/S0021-9258(18)51491-5","volume":"264","author":"S Bannai","year":"1989","unstructured":"Bannai S, Sato H, Ishii T, Sugita Y (1989) Induction of cystine transport activity in human fibroblasts by oxygen. J Biol Chem 264(31):18480\u201318484","journal-title":"J Biol Chem"},{"issue":"2","key":"2_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s004240100537","volume":"442","author":"MT Bassi","year":"2001","unstructured":"Bassi MT, Gasol E, Manzoni M, Pineda M, Riboni M, Martin R et al (2001) Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc. Pflugers Arch 442(2):286\u2013296. https:\/\/doi.org\/10.1007\/s004240100537","journal-title":"Pflugers Arch"},{"issue":"7784","key":"2_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575(7784):688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"issue":"26","key":"2_CR11","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366(26):2455\u20132465. https:\/\/doi.org\/10.1056\/NEJMoa1200694","journal-title":"N Engl J Med"},{"issue":"5","key":"2_CR12","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","volume":"1830","author":"R Brigelius-Flohe","year":"2013","unstructured":"Brigelius-Flohe R, Maiorino M (2013) Glutathione peroxidases. Biochim Biophys Acta 1830(5):3289\u20133303. https:\/\/doi.org\/10.1016\/j.bbagen.2012.11.020","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"2_CR13","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1172\/JCI104186","volume":"39","author":"MP Brigham","year":"1960","unstructured":"Brigham MP, Stein WH, Moore S (1960) The concentrations of cysteine and cystine in human blood plasma. J Clin Invest 39(11):1633\u20131638. https:\/\/doi.org\/10.1172\/JCI104186","journal-title":"J Clin Invest"},{"issue":"6","key":"2_CR14","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris 3rd","year":"1997","unstructured":"Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403\u20132413. https:\/\/doi.org\/10.1200\/JCO.1997.15.6.2403","journal-title":"J Clin Oncol"},{"issue":"2","key":"2_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.dld.2013.09.020","volume":"46","author":"S Cascinu","year":"2014","unstructured":"Cascinu S, Berardi R, Sobrero A, Bidoli P, Labianca R, Siena S et al (2014) Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: a GISCAD randomized phase II study. Dig Liver Dis 46(2):182\u2013186. https:\/\/doi.org\/10.1016\/j.dld.2013.09.020","journal-title":"Dig Liver Dis"},{"issue":"26","key":"2_CR16","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364(26):2507\u20132516. https:\/\/doi.org\/10.1056\/NEJMoa1103782","journal-title":"N Engl J Med"},{"issue":"4","key":"2_CR17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s00259-018-4251-5","volume":"46","author":"MF Cheng","year":"2019","unstructured":"Cheng MF, Huang YY, Ho BY, Kuo TC, Hsin LW, Shiue CY et al (2019) Prospective comparison of (4S)-4-(3-(18)F-fluoropropyl)-L-glutamate versus (18)F-fluorodeoxyglucose PET\/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study. Eur J Nucl Med Mol Imaging 46(4):810\u2013820. https:\/\/doi.org\/10.1007\/s00259-018-4251-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2_CR18","doi-asserted-by":"publisher","unstructured":"Combs JA, DeNicola GM (2019) The non-essential amino acid cysteine becomes essential for tumor proliferation and survival. Cancers 11(5). https:\/\/doi.org\/10.3390\/cancers11050678","DOI":"10.3390\/cancers11050678"},{"issue":"19","key":"2_CR19","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817\u20131825. https:\/\/doi.org\/10.1056\/NEJMoa1011923","journal-title":"N Engl J Med"},{"issue":"15","key":"2_CR20","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-18-3855","volume":"79","author":"B Daher","year":"2019","unstructured":"Daher B, Parks SK, Durivault J, Cormerais Y, Baidarjad H, Tambutte E et al (2019) Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival, and tumor formation via nutrient and oxidative stresses. Cancer Res 79(15):3877\u20133890. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3855","journal-title":"Cancer Res"},{"issue":"5","key":"2_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"2_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M et al (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. elife 3:e02523. https:\/\/doi.org\/10.7554\/eLife.02523","journal-title":"elife"},{"issue":"7784","key":"2_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I et al (2019) FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575(7784):693\u2013698. https:\/\/doi.org\/10.1038\/s41586-019-1707-0","journal-title":"Nature"},{"issue":"3","key":"2_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR (2003) Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3(3):285\u2013296. https:\/\/doi.org\/10.1016\/s1535-6108(03)00050-3","journal-title":"Cancer Cell"},{"issue":"4","key":"2_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/ars.2007.1953","volume":"10","author":"W Droge","year":"2008","unstructured":"Droge W, Kinscherf R (2008) Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid Redox Signal 10(4):661\u2013678. https:\/\/doi.org\/10.1089\/ars.2007.1953","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"2_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.18632\/oncoscience.160","volume":"2","author":"N Eling","year":"2015","unstructured":"Eling N, Reuter L, Hazin J, Hamacher-Brady A, Brady NR (2015) Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2(5):517\u2013532. https:\/\/doi.org\/10.18632\/oncoscience.160","journal-title":"Oncoscience"},{"issue":"Suppl 8","key":"2_CR27","doi-asserted-by":"publisher","first-page":"viii6-9","DOI":"10.1093\/annonc\/mds256","volume":"23","author":"OJ Finn","year":"2012","unstructured":"Finn OJ (2012) Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol 23(Suppl 8):viii6-9. https:\/\/doi.org\/10.1093\/annonc\/mds256","journal-title":"Ann Oncol"},{"issue":"12","key":"2_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ et al (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16(12):1180\u20131191. https:\/\/doi.org\/10.1038\/ncb3064","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/ars.2010.3496","volume":"15","author":"SK Garg","year":"2011","unstructured":"Garg SK, Yan Z, Vitvitsky V, Banerjee R (2011) Differential dependence on cysteine from transsulfuration versus transport during T cell activation. Antioxid Redox Signal 15(1):39\u201347. https:\/\/doi.org\/10.1089\/ars.2010.3496","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"2_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrclinonc.2015.53","volume":"12","author":"I Garrido-Laguna","year":"2015","unstructured":"Garrido-Laguna I, Hidalgo M (2015) Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Nat Rev Clin Oncol 12(6):319\u2013334. https:\/\/doi.org\/10.1038\/nrclinonc.2015.53","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"2_CR31","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/sj.leu.2402238","volume":"15","author":"PW Gout","year":"2001","unstructured":"Gout PW, Buckley AR, Simms CR, Bruchovsky N (2001) Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia 15(10):1633\u20131640","journal-title":"Leukemia"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1101\/sqb.2005.70.033","volume":"70","author":"PB Gupta","year":"2005","unstructured":"Gupta PB, Mani S, Yang J, Hartwell K, Weinberg RA (2005) The evolving portrait of cancer metastasis. Cold Spring Harb Symp Quant Biol 70:291\u2013297. https:\/\/doi.org\/10.1101\/sqb.2005.70.033","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"1","key":"2_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1096\/fasebj.11.1.9034170","volume":"11","author":"V Hack","year":"1997","unstructured":"Hack V, Schmid D, Breitkreutz R, Stahl-Henning C, Drings P, Kinscherf R et al (1997) Cystine levels, cystine flux, and protein catabolism in cancer cachexia, HIV\/SIV infection, and senescence. FASEB J 11(1):84\u201392. https:\/\/doi.org\/10.1096\/fasebj.11.1.9034170","journal-title":"FASEB J"},{"issue":"1","key":"2_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood.V92.1.59.413a05_59_67","volume":"92","author":"V Hack","year":"1998","unstructured":"Hack V, Breitkreutz R, Kinscherf R, Rohrer H, Bartsch P, Taut F et al (1998) The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood 92(1):59\u201367","journal-title":"Blood"},{"issue":"7679","key":"2_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A et al (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551(7679):247\u2013250. https:\/\/doi.org\/10.1038\/nature24297","journal-title":"Nature"},{"issue":"5","key":"2_CR36","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.cmet.2019.01.020","volume":"29","author":"IS Harris","year":"2019","unstructured":"Harris IS, Endress JE, Coloff JL, Selfors LM, McBrayer SK, Rosenbluth JM et al (2019) Deubiquitinases maintain protein homeostasis and survival of cancer cells upon glutathione depletion. Cell Metab 29(5):1166\u20131181. e1166. https:\/\/doi.org\/10.1016\/j.cmet.2019.01.020","journal-title":"Cell Metab"},{"issue":"5340","key":"2_CR37","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1126\/science.278.5340.1064","volume":"278","author":"LH Hartwell","year":"1997","unstructured":"Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH (1997) Integrating genetic approaches into the discovery of anticancer drugs. Science 278(5340):1064\u20131068. https:\/\/doi.org\/10.1126\/science.278.5340.1064","journal-title":"Science"},{"issue":"4","key":"2_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13(4):246\u2013257. https:\/\/doi.org\/10.1038\/nrc3458","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2_CR39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363(8):711\u2013723. https:\/\/doi.org\/10.1056\/NEJMoa1003466","journal-title":"N Engl J Med"},{"issue":"3A","key":"2_CR40","first-page":"1499","volume":"28","author":"K Hoffmann","year":"2008","unstructured":"Hoffmann K, Mehrle S, Schmidt J, Buchler MW, Marten A (2008) Interferon-alpha restitutes the chemosensitivity in pancreatic cancer. Anticancer Res 28(3A):1499\u20131507","journal-title":"Anticancer Res"},{"issue":"8","key":"2_CR41","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3rd et al (2016) Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12(8):1425\u20131428. https:\/\/doi.org\/10.1080\/15548627.2016.1187366","journal-title":"Autophagy"},{"issue":"12","key":"2_CR42","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nrm3896","volume":"15","author":"JD Humphrey","year":"2014","unstructured":"Humphrey JD, Dufresne ER, Schwartz MA (2014) Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol 15(12):802\u2013812. https:\/\/doi.org\/10.1038\/nrm3896","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2_CR43","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-07-5714","volume":"68","author":"RF Hwang","year":"2008","unstructured":"Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A et al (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68(3):918\u2013926. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5714","journal-title":"Cancer Res"},{"issue":"9","key":"2_CR44","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.ejca.2013.03.020","volume":"49","author":"JR Infante","year":"2013","unstructured":"Infante JR, Papadopoulos KP, Bendell JC, Patnaik A, Burris HA 3rd, Rasco D et al (2013) A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours. Eur J Cancer 49(9):2077\u20132085. https:\/\/doi.org\/10.1016\/j.ejca.2013.03.020","journal-title":"Eur J Cancer"},{"issue":"23","key":"2_CR45","doi-asserted-by":"publisher","first-page":"12387","DOI":"10.1016\/S0021-9258(18)43284-X","volume":"256","author":"T Ishii","year":"1981","unstructured":"Ishii T, Bannai S, Sugita Y (1981a) Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine. J Biol Chem 256(23):12387\u201312392","journal-title":"J Biol Chem"},{"issue":"2","key":"2_CR46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jcp.1041070215","volume":"107","author":"T Ishii","year":"1981","unstructured":"Ishii T, Hishinuma I, Bannai S, Sugita Y (1981b) Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol. J Cell Physiol 107(2):283\u2013293. https:\/\/doi.org\/10.1002\/jcp.1041070215","journal-title":"J Cell Physiol"},{"key":"2_CR47","unstructured":"JI M (2012, June 4) Infinity reports update from phase 2 study of saridegib plus gemcitabine in patients with metastatic pancreatic cancer. http:\/\/phx.corporate-ir.net\/phoenix.zhtml?c=121941&p=irol-newsArticle&ID=1653550&highlight"},{"issue":"9","key":"2_CR48","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/S0891-5849(02)01040-7","volume":"33","author":"DP Jones","year":"2002","unstructured":"Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, Sternberg P Jr (2002) Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 33(9):1290\u20131300","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS et al (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol 13(1):81\u201390. https:\/\/doi.org\/10.1038\/nchembio.2238","journal-title":"Nat Chem Biol"},{"issue":"9","key":"2_CR50","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582\u2013598. https:\/\/doi.org\/10.1038\/nrc.2016.73","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2_CR51","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","volume":"120","author":"MH Kalser","year":"1985","unstructured":"Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120(8):899\u2013903. https:\/\/doi.org\/10.1001\/archsurg.1985.01390320023003","journal-title":"Arch Surg"},{"issue":"6","key":"2_CR52","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s11307-016-1007-0","volume":"18","author":"G Kavanaugh","year":"2016","unstructured":"Kavanaugh G, Williams J, Morris AS, Nickels ML, Walker R, Koglin N et al (2016) Utility of [(18)F]FSPG PET to image hepatocellular carcinoma: first clinical evaluation in a US population. Mol Imaging Biol 18(6):924\u2013934. https:\/\/doi.org\/10.1007\/s11307-016-1007-0","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"2_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0005-2736(01)00338-8","volume":"1512","author":"JY Kim","year":"2001","unstructured":"Kim JY, Kanai Y, Chairoungdua A, Cha SH, Matsuo H, Kim DK et al (2001) Human cystine\/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim Biophys Acta 1512(2):335\u2013344. https:\/\/doi.org\/10.1016\/s0005-2736(01)00338-8","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"2_CR54","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nnano.2016.164","volume":"11","author":"SE Kim","year":"2016","unstructured":"Kim SE, Zhang L, Ma K, Riegman M, Chen F, Ingold I et al (2016) Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat Nanotechnol 11(11):977\u2013985. https:\/\/doi.org\/10.1038\/nnano.2016.164","journal-title":"Nat Nanotechnol"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV et al (2016) Pancreatic cancer. Nat Rev Dis Primers 2:16022. https:\/\/doi.org\/10.1038\/nrdp.2016.22","journal-title":"Nat Rev Dis Primers"},{"issue":"31","key":"2_CR56","doi-asserted-by":"publisher","first-page":"12735","DOI":"10.1074\/jbc.R117.786632","volume":"292","author":"MD Knutson","year":"2017","unstructured":"Knutson MD (2017) Iron transport proteins: gateways of cellular and systemic iron homeostasis. J Biol Chem 292(31):12735\u201312743. https:\/\/doi.org\/10.1074\/jbc.R117.786632","journal-title":"J Biol Chem"},{"issue":"18","key":"2_CR57","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1158\/1078-0432.CCR-11-0687","volume":"17","author":"N Koglin","year":"2011","unstructured":"Koglin N, Mueller A, Berndt M, Schmitt-Willich H, Toschi L, Stephens AW et al (2011) Specific PET imaging of xC- transporter activity using a (1)(8)F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism. Clin Cancer Res 17(18):6000\u20136011. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0687","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2_CR58","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H et al (2017) The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol 19(5):518\u2013529. https:\/\/doi.org\/10.1038\/ncb3513","journal-title":"Nat Cell Biol"},{"issue":"30","key":"2_CR59","doi-asserted-by":"publisher","first-page":"E3091","DOI":"10.1073\/pnas.1411679111","volume":"111","author":"JJ Lee","year":"2014","unstructured":"Lee JJ, Perera RM, Wang H, Wu DC, Liu XS, Han S et al (2014) Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc Natl Acad Sci U S A 111(30):E3091\u2013E3100. https:\/\/doi.org\/10.1073\/pnas.1411679111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"2_CR60","doi-asserted-by":"publisher","first-page":"21853","DOI":"10.18632\/oncotarget.5213","volume":"6","author":"TB Levring","year":"2015","unstructured":"Levring TB, Kongsbak M, Rode AK, Woetmann A, Odum N, Bonefeld CM et al (2015) Human CD4+ T cells require exogenous cystine for glutathione and DNA synthesis. Oncotarget 6(26):21853\u201321864. https:\/\/doi.org\/10.18632\/oncotarget.5213","journal-title":"Oncotarget"},{"issue":"5","key":"2_CR61","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW et al (2013) The cystine\/glutamate antiporter system x(c)(\u2212) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18(5):522\u2013555. https:\/\/doi.org\/10.1089\/ars.2011.4391","journal-title":"Antioxid Redox Signal"},{"issue":"19","key":"2_CR62","doi-asserted-by":"publisher","first-page":"9433","DOI":"10.1073\/pnas.1821323116","volume":"116","author":"JKM Lim","year":"2019","unstructured":"Lim JKM, Delaidelli A, Minaker SW, Zhang HF, Colovic M, Yang H et al (2019) Cystine\/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Proc Natl Acad Sci U S A 116(19):9433\u20139442. https:\/\/doi.org\/10.1073\/pnas.1821323116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2_CR63","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/sj.bjc.6604485","volume":"99","author":"M Lo","year":"2008","unstructured":"Lo M, Ling V, Wang YZ, Gout PW (2008) The xc- cystine\/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Br J Cancer 99(3):464\u2013472. https:\/\/doi.org\/10.1038\/sj.bjc.6604485","journal-title":"Br J Cancer"},{"issue":"4","key":"2_CR64","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704\u2013715. https:\/\/doi.org\/10.1016\/j.cell.2008.03.027","journal-title":"Cell"},{"key":"2_CR65","unstructured":"Medicine UNLo (2014). Clinicaltrials.gov [online]"},{"key":"2_CR113","doi-asserted-by":"publisher","unstructured":"Meira W, Daher B, Parks SK, Cormerais Y, Durivault J, Tambutte E et al (2021) A Cystine-Cysteine Intercellular Shuttle Prevents Ferroptosis in xCT(KO) Pancreatic Ductal Adenocarcinoma Cells. Cancers (Basel) 13 (6). https:\/\/doi.org\/10.3390\/cancers13061434","DOI":"10.3390\/cancers13061434"},{"issue":"2","key":"2_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148628","volume":"11","author":"ES Mittra","year":"2016","unstructured":"Mittra ES, Koglin N, Mosci C, Kumar M, Hoehne A, Keu KV et al (2016) Pilot preclinical and clinical evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET\/CT imaging of intracranial malignancies. PLoS One 11(2):e0148628. https:\/\/doi.org\/10.1371\/journal.pone.0148628","journal-title":"PLoS One"},{"issue":"15","key":"2_CR67","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","volume":"25","author":"MJ Moore","year":"2007","unstructured":"Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25(15):1960\u20131966. https:\/\/doi.org\/10.1200\/JCO.2006.07.9525","journal-title":"J Clin Oncol"},{"issue":"8","key":"2_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002888","volume":"3","author":"AP Morel","year":"2008","unstructured":"Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3(8):e2888. https:\/\/doi.org\/10.1371\/journal.pone.0002888","journal-title":"PLoS One"},{"issue":"12","key":"2_CR69","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.freeradbiomed.2003.09.006","volume":"35","author":"SE Moriarty","year":"2003","unstructured":"Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, Jones DP et al (2003) Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med 35(12):1582\u20131588","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"2_CR70","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1148\/radiol.2015142000","volume":"279","author":"C Mosci","year":"2016","unstructured":"Mosci C, Kumar M, Smolarz K, Koglin N, Stephens AW, Schwaiger M et al (2016) Characterization of physiologic (18)F FSPG uptake in healthy volunteers. Radiology 279(3):898\u2013905. https:\/\/doi.org\/10.1148\/radiol.2015142000","journal-title":"Radiology"},{"issue":"12","key":"2_CR71","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350(12):1200\u20131210. https:\/\/doi.org\/10.1056\/NEJMoa032295","journal-title":"N Engl J Med"},{"issue":"7","key":"2_CR72","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1158\/1078-0432.CCR-06-2746","volume":"13","author":"T Nomi","year":"2007","unstructured":"Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H et al (2007) Clinical significance and therapeutic potential of the programmed death-1 ligand\/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res 13(7):2151\u20132157. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2746","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2_CR73","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s0002-9610(00)00369-x","volume":"179","author":"Y Nukui","year":"2000","unstructured":"Nukui Y, Picozzi VJ, Traverso LW (2000) Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 179(5):367\u2013371. https:\/\/doi.org\/10.1016\/s0002-9610(00)00369-x","journal-title":"Am J Surg"},{"issue":"1","key":"2_CR74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL et al (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13(1):54\u201361. https:\/\/doi.org\/10.1038\/nm1523","journal-title":"Nat Med"},{"issue":"3","key":"2_CR75","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297(3):267\u2013277. https:\/\/doi.org\/10.1001\/jama.297.3.267","journal-title":"JAMA"},{"issue":"5933","key":"2_CR76","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D et al (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324(5933):1457\u20131461. https:\/\/doi.org\/10.1126\/science.1171362","journal-title":"Science"},{"issue":"12","key":"2_CR77","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1093\/annonc\/mdv477","volume":"26","author":"BH O\u2019Neil","year":"2015","unstructured":"O\u2019Neil BH, Scott AJ, Ma WW, Cohen SJ, Leichman L, Aisner DL et al (2015) A phase II\/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Ann Oncol 26(12):2505. https:\/\/doi.org\/10.1093\/annonc\/mdv477","journal-title":"Ann Oncol"},{"issue":"5","key":"2_CR78","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/emboj.2009.1","volume":"28","author":"T Panaretakis","year":"2009","unstructured":"Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC et al (2009) Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 28(5):578\u2013590. https:\/\/doi.org\/10.1038\/emboj.2009.1","journal-title":"EMBO J"},{"issue":"12","key":"2_CR79","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15(12):1243\u20131253. https:\/\/doi.org\/10.15252\/embr.201439246","journal-title":"EMBO Rep"},{"issue":"3","key":"2_CR80","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","volume":"21","author":"PP Provenzano","year":"2012","unstructured":"Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR (2012) Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 21(3):418\u2013429. https:\/\/doi.org\/10.1016\/j.ccr.2012.01.007","journal-title":"Cancer Cell"},{"issue":"11","key":"2_CR81","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"2_CR82","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F et al (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148(1\u20132):349\u2013361. https:\/\/doi.org\/10.1016\/j.cell.2011.11.025","journal-title":"Cell"},{"issue":"6","key":"2_CR83","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA et al (2014) Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25(6):735\u2013747. https:\/\/doi.org\/10.1016\/j.ccr.2014.04.021","journal-title":"Cancer Cell"},{"issue":"3","key":"2_CR84","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/embor.2013.5","volume":"14","author":"SJ Ricoult","year":"2013","unstructured":"Ricoult SJ, Manning BD (2013) The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep 14(3):242\u2013251. https:\/\/doi.org\/10.1038\/embor.2013.5","journal-title":"EMBO Rep"},{"key":"2_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2407-6-29","volume":"6","author":"PA Robe","year":"2006","unstructured":"Robe PA, Martin D, Albert A, Deprez M, Chariot A, Bours V (2006) A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. BMC Cancer 6:29. https:\/\/doi.org\/10.1186\/1471-2407-6-29","journal-title":"BMC Cancer"},{"key":"2_CR86","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/1471-2407-9-372","volume":"9","author":"PA Robe","year":"2009","unstructured":"Robe PA, Martin DH, Nguyen-Khac MT, Artesi M, Deprez M, Albert A et al (2009) Early termination of ISRCTN45828668, a phase 1\/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer 9:372. https:\/\/doi.org\/10.1186\/1471-2407-9-372","journal-title":"BMC Cancer"},{"issue":"7","key":"2_CR87","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S1590-8658(03)00221-4","volume":"35","author":"GH Sakorafas","year":"2003","unstructured":"Sakorafas GH, Sarr MG (2003) Pancreatic cancer after surgery for chronic pancreatitis. Dig Liver Dis 35(7):482\u2013485","journal-title":"Dig Liver Dis"},{"issue":"47","key":"2_CR88","doi-asserted-by":"publisher","first-page":"44765","DOI":"10.1074\/jbc.M208704200","volume":"277","author":"H Sasaki","year":"2002","unstructured":"Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H et al (2002) Electrophile response element-mediated induction of the cystine\/glutamate exchange transporter gene expression. J Biol Chem 277(47):44765\u201344771. https:\/\/doi.org\/10.1074\/jbc.M208704200","journal-title":"J Biol Chem"},{"issue":"45","key":"2_CR89","doi-asserted-by":"publisher","first-page":"37423","DOI":"10.1074\/jbc.M506439200","volume":"280","author":"H Sato","year":"2005","unstructured":"Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y et al (2005) Redox imbalance in cystine\/glutamate transporter-deficient mice. J Biol Chem 280(45):37423\u201337429. https:\/\/doi.org\/10.1074\/jbc.M506439200","journal-title":"J Biol Chem"},{"issue":"1","key":"2_CR90","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","volume":"8","author":"M Sato","year":"2018","unstructured":"Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y et al (2018) The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells. Sci Rep 8(1):968. https:\/\/doi.org\/10.1038\/s41598-018-19213-4","journal-title":"Sci Rep"},{"issue":"10","key":"2_CR91","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA (2017) EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol 14(10):611\u2013629. https:\/\/doi.org\/10.1038\/nrclinonc.2017.44","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"2_CR92","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/MOG.0000000000000295","volume":"32","author":"S Sinha","year":"2016","unstructured":"Sinha S, Leach SD (2016) New insights in the development of pancreatic cancer. Curr Opin Gastroenterol 32(5):394\u2013400. https:\/\/doi.org\/10.1097\/MOG.0000000000000295","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"2_CR93","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s002689900215","volume":"21","author":"C Sperti","year":"1997","unstructured":"Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21(2):195\u2013200","journal-title":"World J Surg"},{"issue":"26","key":"2_CR94","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366(26):2443\u20132454. https:\/\/doi.org\/10.1056\/NEJMoa1200690","journal-title":"N Engl J Med"},{"issue":"1","key":"2_CR95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000084492","volume":"5","author":"JF Tseng","year":"2005","unstructured":"Tseng JF, Willett CG, Fernandez-del Castillo C, Ryan DP, Clark JW, Zhu AX et al (2005) Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations. Pancreatology 5(1):67\u201374. https:\/\/doi.org\/10.1159\/000084492","journal-title":"Pancreatology"},{"issue":"2","key":"2_CR96","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","volume":"710","author":"F Ursini","year":"1982","unstructured":"Ursini F, Maiorino M, Valente M, Ferri L, Gregolin C (1982) Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim Biophys Acta 710(2):197\u2013211. https:\/\/doi.org\/10.1016\/0005-2760(82)90150-3","journal-title":"Biochim Biophys Acta"},{"issue":"7664","key":"2_CR97","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B et al (2017) Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547(7664):453\u2013457. https:\/\/doi.org\/10.1038\/nature23007","journal-title":"Nature"},{"issue":"6127","key":"2_CR98","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW (2013) Cancer genome landscapes. Science 339(6127):1546\u20131558. https:\/\/doi.org\/10.1126\/science.1235122","journal-title":"Science"},{"issue":"18","key":"2_CR99","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691\u20131703. https:\/\/doi.org\/10.1056\/NEJMoa1304369","journal-title":"N Engl J Med"},{"key":"2_CR100","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3389\/fonc.2017.00319","volume":"7","author":"M Vucetic","year":"2017","unstructured":"Vucetic M, Cormerais Y, Parks SK, Pouyssegur J (2017) The central role of amino acids in cancer redox homeostasis: vulnerability points of the cancer redox code. Front Oncol 7:319. https:\/\/doi.org\/10.3389\/fonc.2017.00319","journal-title":"Front Oncol"},{"issue":"5","key":"2_CR101","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","volume":"165","author":"W Wang","year":"2016","unstructured":"Wang W, Kryczek I, Dostal L, Lin H, Tan L, Zhao L et al (2016) Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer. Cell 165(5):1092\u20131105. https:\/\/doi.org\/10.1016\/j.cell.2016.04.009","journal-title":"Cell"},{"issue":"7755","key":"2_CR102","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gijon M, Kennedy PD, Johnson JK et al (2019) CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569(7755):270\u2013274. https:\/\/doi.org\/10.1038\/s41586-019-1170-y","journal-title":"Nature"},{"issue":"10018","key":"2_CR103","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","volume":"387","author":"A Wang-Gillam","year":"2016","unstructured":"Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G et al (2016) Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet 387(10018):545\u2013557. https:\/\/doi.org\/10.1016\/S0140-6736(15)00986-1","journal-title":"Lancet"},{"issue":"9","key":"2_CR104","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","volume":"8","author":"SC Wei","year":"2018","unstructured":"Wei SC, Duffy CR, Allison JP (2018) Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov 8(9):1069\u20131086. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0367","journal-title":"Cancer Discov"},{"issue":"4","key":"2_CR105","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1158\/2326-6066.CIR-14-0215","volume":"3","author":"R Winograd","year":"2015","unstructured":"Winograd R, Byrne KT, Evans RA, Odorizzi PM, Meyer AR, Bajor DL et al (2015) Induction of T-cell immunity overcomes complete resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic carcinoma. Cancer Immunol Res 3(4):399\u2013411. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0215","journal-title":"Cancer Immunol Res"},{"issue":"7769","key":"2_CR106","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR et al (2019) Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature 572(7769):402\u2013406. https:\/\/doi.org\/10.1038\/s41586-019-1426-6","journal-title":"Nature"},{"issue":"7146","key":"2_CR107","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ et al (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447(7146):864\u2013868. https:\/\/doi.org\/10.1038\/nature05859","journal-title":"Nature"},{"issue":"3","key":"2_CR108","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3892\/ijo.2018.4259","volume":"52","author":"Y Yamaguchi","year":"2018","unstructured":"Yamaguchi Y, Kasukabe T, Kumakura S (2018) Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis. Int J Oncol 52(3):1011\u20131022. https:\/\/doi.org\/10.3892\/ijo.2018.4259","journal-title":"Int J Oncol"},{"issue":"3","key":"2_CR109","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang WS, Stockwell BR (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 15(3):234\u2013245. https:\/\/doi.org\/10.1016\/j.chembiol.2008.02.010","journal-title":"Chem Biol"},{"issue":"1\u20132","key":"2_CR110","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010","journal-title":"Cell"},{"issue":"7211","key":"2_CR111","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature07275","volume":"455","author":"RL Yauch","year":"2008","unstructured":"Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP et al (2008) A paracrine requirement for hedgehog signalling in cancer. Nature 455(7211):406\u2013410. https:\/\/doi.org\/10.1038\/nature07275","journal-title":"Nature"},{"issue":"5","key":"2_CR112","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Tan H, Daniels JD, Zandkarimi F, Liu H, Brown LM et al (2019) Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biol 26(5):623\u2013633. https:\/\/doi.org\/10.1016\/j.chembiol.2019.01.008","journal-title":"Cell Chem Biol"}],"container-title":["Advances in Experimental Medicine and Biology","Ferroptosis: Mechanism and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-62026-4_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:36:15Z","timestamp":1662165375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-62026-4_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030620257","9783030620264"],"references-count":113,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-62026-4_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"10 August 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}